search
Back to results

Platelet-rich-plasma Treating Tennis Elbow

Primary Purpose

Pain

Status
Completed
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
PRP Injection
Corticosteroid Injection
Sponsored by
Zimmer Biomet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain focused on measuring Tennis Elbow

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient with chronic epicondylitis lateralis who do not react to conservative treatment and therefore are send to the orthopedic surgeon

Exclusion Criteria:

Sites / Locations

  • Elisabeth ziekenhuis

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

1

2

Arm Description

PRP injection

Corticosteroid Injection

Outcomes

Primary Outcome Measures

Visual Analog Score - Pain

Secondary Outcome Measures

DASH
Complications

Full Information

First Posted
September 22, 2008
Last Updated
May 17, 2017
Sponsor
Zimmer Biomet
search

1. Study Identification

Unique Protocol Identification Number
NCT00757289
Brief Title
Platelet-rich-plasma Treating Tennis Elbow
Official Title
Use of Platelet-rich-plasma to Treat Tennis Elbow, A Blinded and Randomized Single Center Study
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
August 2007 (undefined)
Primary Completion Date
January 2008 (Actual)
Study Completion Date
January 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Zimmer Biomet

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The study is to compare the efficacy of autologous platelet concentrate injections to corticosteroid injection in patients suffering from tennis elbow with respect to pain and function.
Detailed Description
Patients with chronic plantar fasciitis will be allocated randomly to have a steroid injection or an autologous platelet concentrate injections. Data will be collected before the procedure, 4, 8, 12, 26 weeks and 1 year after the procedure. The main outcome measures of this study are pain and function measured with questionnaires.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain
Keywords
Tennis Elbow

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
106 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
PRP injection
Arm Title
2
Arm Type
Active Comparator
Arm Description
Corticosteroid Injection
Intervention Type
Biological
Intervention Name(s)
PRP Injection
Intervention Description
PRP Injection
Intervention Type
Biological
Intervention Name(s)
Corticosteroid Injection
Intervention Description
Corticosteroid Injection
Primary Outcome Measure Information:
Title
Visual Analog Score - Pain
Time Frame
4months,12 months,24months & 52 months
Secondary Outcome Measure Information:
Title
DASH
Time Frame
4months,12months,24months & 52 months
Title
Complications
Time Frame
Anytime

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient with chronic epicondylitis lateralis who do not react to conservative treatment and therefore are send to the orthopedic surgeon Exclusion Criteria:
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Taco Gosens, MD
Organizational Affiliation
Elisabeth ziekenhuis
Official's Role
Principal Investigator
Facility Information:
Facility Name
Elisabeth ziekenhuis
City
Tilburg
Country
Netherlands

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Platelet-rich-plasma Treating Tennis Elbow

We'll reach out to this number within 24 hrs